"description","name","id","label","instanceType","text","uuid:ID"
"Main objective","OBJ1","Objective_1","","OBJECTIVE","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","c389b703-41e8-488b-82d3-6dad0956ca78"
"Safety","OBJ2","Objective_2","","OBJECTIVE","To document the safety profile of the xanomeline TTS.","2ed7d018-4701-43a7-95d7-77094b9b628e"
"Behaviour","OBJ3","Objective_3","","OBJECTIVE","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","2e48f975-2f77-4aeb-858e-9073434b3757"
